Faster infection test for bloodstream infections
Part of Infections clinical trials.
This trial tests a rapid diagnostic method that identifies the bacteria in your blood more quickly than standard tests. If it works, doctors can pick the right antibiotic sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a suspected infection in your bloodstream
- A blood culture has already shown bacteria growing
- You are in a hospital ward or intensive care unit
- You or your legal representative can sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new, faster way to choose the right antibiotic for people with a blood infection caused by Enterobacterales bacteria. The goal is to see if this quick test helps doctors start the most effective treatment sooner.
This trial tests a new rapid blood test (Cobas Eplex) that may help doctors identify the cause of a bloodstream infection faster than standard methods. If you are an adult or child hospitalized for a blood infection, this study could lead to quicker, more targeted treatment.
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
This study tests a new machine learning method to quickly identify bacteria in the blood using special sample bottles. If you are getting blood cultures done already, this may help get results faster.
This study tests a new blood test (Microbio InfectID-BSI) to see how well it detects bacteria and yeast in patients with a possible bloodstream infection. If you are already having a blood culture done, the study will collect extra blood samples at the same time to compare the new test's results.
This study tests a new rapid test (NuRapid-CRISPR) that quickly identifies the bacteria or fungus causing a serious blood infection in ICU patients. The goal is to help doctors start the right treatment faster and improve patient outcomes.
Hear when a new Bloodstream Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.